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Mitochondrial fusion requires the coordinated fusion of the outer and inner membranes. Three large GTPases—OPA1
and the mitofusins Mfn1 and Mfn2—are essential for the fusion of mammalian mitochondria. OPA1 is mutated in
dominant optic atrophy, a neurodegenerative disease of the optic nerve. In yeast, the OPA1 ortholog Mgm1 is required
for inner membrane fusion in vitro; nevertheless, yeast lacking Mgm1 show neither outer nor inner membrane fusion in
vivo, because of the tight coupling between these two processes. We find that outer membrane fusion can be readily
visualized in OPA1-null mouse cells in vivo, but these events do not progress to inner membrane fusion. Similar defects
are found in cells lacking prohibitins, which are required for proper OPA1 processing. In contrast, double Mfn-null cells
show neither outer nor inner membrane fusion. Mitochondria in OPA1-null cells often contain multiple matrix compart-
ments bounded together by a single outer membrane, consistent with uncoupling of outer versus inner membrane fusion.
In addition, unlike mitofusins and yeast Mgm1, OPA1 is not required on adjacent mitochondria to mediate membrane
fusion. These results indicate that mammalian mitofusins and OPA1 mediate distinct sequential fusion steps that are
readily uncoupled, in contrast to the situation in yeast.
INTRODUCTION
Mitochondria are dynamic organelles that continually ex-
change contents through membrane fusion. Mitochondrial
fusion controls the morphology of the organelle and is crit-
ically important for maintaining the function of the mito-
chondrial network. Loss of fusion has been linked to re-
duced respiratory activity, embryonic lethality, apoptosis,
and neurodegeneration (Okamoto and Shaw, 2005; Detmer
and Chan, 2007; Suen et al., 2008). In addition, mutations in
Mfn2 and OPA1, two genes involved in mitochondrial fu-
sion, cause the human neurodegenerative diseases Charcot-
Marie-Tooth type 2A (CMT2A) (Zuchner et al., 2004) and
dominant optic atrophy (DOA) (Alexander et al., 2000; Delettre
et al., 2000), respectively.
Mitochondrial fusion is a multi-step process requiring the
coordinated fusion of both the outer and inner membranes,
ultimately resulting in mixing of matrix contents. The coor-
dination of outer and inner membrane fusion has been stud-
ied in budding yeast (Sesaki et al., 2003; Wong et al., 2003;
Meeusen et al., 2006; Hoppins et al., 2007). In yeast, the outer
membrane proteins Fzo1p and Ugo1p and the inner mem-
brane protein Mgm1p are essential for mitochondrial fusion.
In an in vitro mitochondrial fusion assay, Mgm1p is re-
quired for fusion of the inner but not outer mitochondrial
membranes (Meeusen et al., 2006). However, in vivo, yeast
lacking Mgm1 have no outer membrane fusion (Sesaki et al.,
2003). Ugo1p forms a complex with both Fzo1p and Mgm1p
and may coordinate the activity of both proteins (Wong et
al., 2003; Sesaki and Jensen, 2004).
In mammals, mitochondrial fusion requires the action of
three large GTPases: the mitofusins (Mfns) Mfn1 and Mfn2,
which are orthologues of Fzo1p, and the dynamin-related
protein OPA1, which is the ortholog of Mgm1p (Chen et al.,
2003; Cipolat et al., 2004; Chen et al., 2005; Chan, 2006). The
coordination of outer membrane versus inner membrane
fusion in mammalian mitochondria can be disrupted by
pharmacological treatments (Malka et al., 2005), but the mo-
lecular basis of this uncoupling has not been characterized.
To address whether these large GTPases act at distinct steps
during mitochondrial fusion, we have developed assays to
analyze mitochondrial outer membrane fusion in mouse
embryonic fibroblasts (MEFs) containing null alleles of
OPA1 or both mitofusins. Our results provide clear evidence
that mitofusins act early and are essential for outer mem-
brane fusion, whereas OPA1 is required for only inner mem-
brane fusion. In addition, we find several differences in the
properties of mitochondrial fusion between yeast and mam-
mals.
MATERIALS AND METHODS
Cell Culture and Retroviral Expression
All cell lines were grown in Dulbecco’s Modified Eagle’s Medium supple-
mented with 10% FBS, 1 mM L-glutamine, penicillin, and streptomycin. Cells
were cultured in a humidified atmosphere containing 5% CO2 at 37°C.
PA-GFP-OMP25 was constructed by inserting a segment encoding the last
37 amino acids of OMP25 in frame with PA-GFP. The terminal residues of
OMP25 have been shown to be sufficient to direct localization to the mito-
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chondrial outer membrane (Nemoto and De Camilli, 1999). To construct
mCherry-OMP25, mCherry was amplified by PCR and cloned in-frame to the
last 37 amino acids of OMP25. Mito-PA-GFP (provided by Richard Youle,
National Institutes of Health), PA-GFP-OMP25, and mCherry-OMP25 were
subcloned into the Moloney-based retroviral vector pCLW. Retroviral stocks
were produced by cotransfection of 293T cells with retroviral constructs and
the ecotropic retroviral packaging vector pCL-Eco using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) according the manufacturer’s protocol.
A retroviral shRNAi construct for Phb1 was made as previously described




CAAGTCggg 3. The retroviral construct targets the sequence gacttgcagaacgt-
caata in mouse Phb1.
PEG Fusion Assay
MEFs expressing mitochondrially targeted DsRed or mCherry were coplated
with MEFs expressing mitochondrially targeted enhanced green fluorescent
protein (EGFP). The next morning, cells were incubated with PEG 1500
(Roche, Indianapolis, IN) for exactly 1 min at room temperature and then
washed with medium 3 times. The cells were then cultured in medium
containing 33 g/ml cyclohexmide for 1 or 7 h. The cultures were fixed in
10% Formalin, and the coverslips were then mounted onto microscope slides
with GelMount (Biomeda, Foster City, CA).
Confocal Microscopy and Image Processing
Confocal microscopy was performed with a Zeiss LSM 510 Meta microscope
with a 100 oil-immersion objective. Live cells were maintained at 37°C
under mineral oil. In cells expressing mito-PA-GFP or PA-GFP-OMP25, mi-
tochondria within a region of interest were photoactivated with a two-photon
laser set at 750 nm. With the multi-track scanning mode, mt-DsRed was
imaged by excitation with a 1-mW 543-nm helium/neon laser, with emission
recorded through an LP560-nm filter. EGFP or photoactivated PA-GFP was
imaged by excitation with a 25-mW 488-nm argon laser, with emission
recorded through a BP 500–560-nm filter.
Image processing and analysis were performed with ImageJ software.
Individual mitochondria were selected manually in each still frame, and its
fluorescence intensity, corrected for background fluorescence, was recorded.
Mitochondria were randomly selected for quantitative analysis.
Electron Microscopy
Cultured cells were prepared for electron microscopy as previously described
(Perkins and McCaffery, 2007). Briefly, cells were fixed at room temperature
(3.0% formaldehyde, 1.5% glutaraldehyde, 0.1 M sodium cacodylate, 5 mM
Ca2, 2.5% sucrose pH 7.4 buffer) and stored at 4°C. Cells were washed 3
times in ice-cold 0.1 M sodium cacodylate containing 2.5% sucrose and then
postfixed in Palade’s OsO4 for 1 h on ice in the dark. After washing 3 times
with 0.06 M veronol acetate, the fixed cell pellet was stained and stabilized en
bloc with Kellenberger’s uranyl acetate at room temperature in the dark. After
one rinse with 50% ethanol (4°C) the cells were dehydrated at 4°C through a
graded series of ethanol (70%, 95%, 100%) for 5 min each and treated 3 times
for 5 min each in fresh 100% acetone at room temperature. Cells were then
infiltrated in a well-mixed Epon-acetone resin series of 33% for 3 h, 66% for
6 h followed by 100% at least overnight with agitation at room temperature,
after which the samples were allowed to polymerize in 100% Epon blocks at
60°C for 48 h. For conventional electron microscopy, sections of 80 nm were
cut using a diamond knife and poststained with 2% uranyl acetate and lead
citrate. For electron tomography, sections of 300 nm were cut and post-
stained with 2% uranyl acetate and lead citrate. Colloidal gold particles were
applied (10 nm) for use as fiducial marks for alignment before recording
single axis tilt series at 2° from60° to 60° on an FEI Tecnai 12 transmission
electron microscope operated at 120 kV with images recorded on a Tietz 214
CCD camera. Tomograms were calculated from the tilt series, segmented, and
displayed as described previously (Sun et al., 2007).
RESULTS
OPA1 Is Not Required on Adjacent Mitochondria for
Fusion
We previously showed that both Mfn-null cells (double null
cells lacking Mfn1 and Mfn2) and OPA1-null cells lack any
detectable mitochondrial fusion activity (Koshiba et al., 2004;
Chen et al., 2005; Song et al., 2007), as measured in fusion
assays that monitor mixing of fluorescent proteins targeted
to the mitochondrial matrix. One of the key properties of
mitofusins is that they are required on adjacent mitochon-
dria during fusion, supporting their proposed role in teth-
ering the outer mitochondrial membranes (Koshiba et al.,
2004). To test whether there is a similar requirement for
OPA1 function, we performed PEG cell hybrid assays in
which OPA1-null cells containing DsRed in the mitochon-
drial matrix were fused against wild-type cells containing
EGFP in the mitochondrial matrix. In 95% of the cell hybrids,
we detected substantial colocalization of DsRed and EGFP,
indicating fusion of both the outer and inner membranes to
yield merging of the contents of the mitochondrial matrix
(Figure 1). In 7% of the cell hybrids, all the mitochondria
showed colocalization of DsRed and EGFP (Figure 1B;
scored as “full fusion”). In the other 88% of cell hybrids,
clear colocalization of DsRed and EGFP was found in a
fraction of the mitochondrial population (scored as “partial
fusion”). Many of the DsRed-containing mitochondria in
these OPA1-null/wild-type cell hybrids were elongated tu-
bules, whereas mitochondria of the OPA1-null parental cells
Figure 1. Distinct requirements for mitofusins and OPA1 in mito-
chondrial fusion. (A) Representative images of three PEG cell hy-
brid fusion assays done by fusing the parental cells indicated on the
right. In the bottom two panels, the mutant cells (Mfn-null or
OPA1-null) express mito-DsRed, whereas the wild-type cell (WT)
expresses mito-EGFP. In the bottom panel, a cell hybrid between a
wild-type and an OPA1-null cell shows extensive mixing of the
green (left panel) and red (middle panel) fluorophores. Some elon-
gated mitochondrial tubules containing DsRed in the cell hybrid are
indicated by arrows. (B) Quantitation of the PEG cell hybrid exper-
iments. Error bars indicate standard deviations from 3 independent
experiments in which 100 cell hybrids were scored. The cell hybrids
were scored by estimating the percentage of mitochondria showing
colocalization of fluorophores. Full fusion indicates that all the
mitochondria in the cell hybrid contained both fluorophores. Cell
hybrids with a combination with fused and unfused mitochondria
were scored as partial fusion. Hybrids with no doubly stained
mitochondria were scored as no fusion.
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were completely fragmented. This observation is consistent
with the conclusion that substantial mitochondrial fusion has
occurred. In contrast, cell hybrids between two OPA1-null cells
show no mitochondrial fusion (Song et al., 2007). In agreement
with previous studies, no mitochondrial fusion was detected
when Mfn-null cells were fused with wild-type cells.
The results above indicate that OPA1 is needed on only
one mitochondrion to facilitate fusion between a pair. It
should be noted, though, that multiple OPA1 isoforms arise
through differential RNA splicing and protein processing.
Long isoforms of OPA1 are anchored to the inner mem-
brane, whereas short isoforms have no apparent membrane
anchor. A combination of long and short isoforms is neces-
sary for fusion activity (Song et al., 2007). One potential
concern is that short isoforms of OPA1 can diffuse in the
intermembrane space if outer membrane fusion occurs, com-
plicating the interpretation of the PEG cell hybrid results. To
address this concern, we used the recent observation that an
OPA1 long isoform alone can promote fusion in the presence
of cycloheximide, in contrast to the requirement for a com-
bination of long and short forms during normal cell growth
(Tondera et al., 2009). Consistent with this study, we found
that whereas OPA1-null cells expressing isoform 1S1, a
noncleavable long form of OPA1 isoform 1 (Song et al., 2007),
have fragmented mitochondria, incubation with cyclohexi-
mide leads to formation of more elongated mitochondria
(Figure S1, A and B). Western blot analysis showed that the
elongation of mitochondria with cycloheximide treatment
was not attributable to production of a short form of OPA1
(Figure S1C). In contrast, cells expressing isoform 3, which
produces only a short form, showed fragmented mitochon-
dria under both conditions.
Because cycloheximide is used to inhibit protein synthesis
during the PEG fusion assay, we asked whether the mem-
brane-bound long form of isoform 1 could mediate mito-
chondrial fusion when present on only one of the parental
cells. When OPA1-null cells expressing 1S1 were fused
with OPA1-null cells, we found that 50% of the cell hy-
brids contained substantial mitochondrial fusion (Figure 2).
This observation further supports the idea that OPA1, unlike
mitofusins, is not needed on adjacent mitochondria promote
fusion.
Outer Membrane Fusion in OPA1-Null Cells in the PEG
Fusion Assay
To study the function of mitofusins and OPA1 in mito-
chondrial outer membrane fusion, we used the PEG cell
hybrid assay with one of the parental cell lines expressing
mCherry fused to the membrane targeting sequence of
OMP25 (Nemoto and De Camilli, 1999), a mitochondrial
outer membrane protein. At the standard 7-h time point used
for PEG cell fusion experiments, we found that OPA1-null
cell hybrids showed extensive mixing of mCherry-OMP25
throughout the mitochondrial population (Figure S2). Under
these conditions, however, Mfn-null cells also showed mix-
ing of the outer membrane marker, although less extensively
(Figure S2). We were concerned that the extended time used
in a standard PEG cell hybrid experiment might lead to
artifactual results with the outer membrane marker. When
we repeated these experiments using shorter incubation
times, we found a marked difference in the extent of
mCherry-OMP25 mixing in OPA1-null cells versus Mfn-null
cells (Figure 3). At 1 h after cell fusion, Mfn-null hybrids
show little evidence for outer membrane fusion, whereas
more than 95% of OPA1-null hybrids show clear partial
fusion (Figure 3B). These results suggest that outer mem-
Figure 2. Mitochondrial fusion in hybrids of parental cells with
different OPA1 isoforms. Mitochondrial fusion was measured in cell
hybrids between wild-type cells, OPA1-null cells, or OPA1-null cells
expressing the indicated OPA1 isoforms. Error bars indicate SD
from 3 experiments.
Figure 3. Outer membrane fusion in OPA1-null cells. (A) Repre-
sentative images of three PEG cell hybrid fusion assays done by
fusing the parental cells indicated on the right and analyzing cells
1 h after cell fusion. Mitochondrial outer membrane mixing was
monitored with mCherry-OMP25. In the bottom panel, an OPA1-
null cell hybrid shows partial mixing of the green (left panel) and
red (middle panel) fluorophores. The large inset is a magnified
image of the small box. Arrows highlight individual mitochondria
within the inset. (B) Quantitation of the PEG cell hybrid experi-
ments. Scoring and quantitation was done as for Figure 1B, except
that because cells only showed partial mitochondrial fusion at 1 h,
the partial fusion category was further separated into cells in which
greater or 50% of the mitochondria showed fluorophore mixing.
Error bars indicate SD from 3 experiments.
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brane fusion occurs in OPA1-null cells. However, our results
also suggest that the PEG cell hybrid assay is not an ideal
system to measure mitochondrial outer membrane fusion. It
is possible that the residual mCherry-OMP25 mixing in Mfn-
null cells reflects an artifact of the PEG fusion assay. Because
of this concern, we decided to develop an assay to directly
visualize outer membrane fusion events in real-time.
Outer Membrane Fusion Observed in OPA1-Null Cells
With a New Outer Membrane Fusion Assay
We adopted an assay (Karbowski et al., 2004; Haigh et al.,
2007) for mitochondrial fusion that uses photoactivatible
GFP (PA-GFP), a GFP derivative whose fluorescence increases
100-fold upon photoactivation (Patterson and Lippincott-
Schwartz, 2002). In this assay, cells express both mito-PA-
GFP and mito-DsRed, variants that are targeted to the mi-
tochondrial matrix. Within a single cell, a small subset of
mito-PA-GFP–labeled mitochondria is photoactivated by
2-photon excitation and then tracked by time-lapse micros-
copy. In wild-type cells, mitochondrial fusion causes the
PA-GFP in photoactivated mitochondria to transfer to non-
activated mitochondria. Because mitochondrial fusion re-
sults in content exchange, such events are characterized by
sudden stepwise changes in PA-GFP and DsRed fluores-
cence (Figure S3). In cells where mitochondrial fusion activ-
ity is high, the PA-GFP fluorescence intensity in the acti-
vated mitochondria is steadily diluted because of cycles of
fusion with surrounding mitochondria. In cells with little or
no mitochondrial fusion, however, the PA-GFP fluorescence
in the activated mitochondria remains stable, apart from
fading attributable to photobleaching. As expected, both
OPA1-null and Mfn-null cells behave similarly in this assay,
with activated mito-PA-GFP showing only modest declines
in fluorescence over a 20 min recording session (Figure 4,
A–C). In addition, inspection of individual mitochondria in
the time-lapse movies revealed no evidence for matrix mix-
ing. In both cell lines, we tabulated the fluorescence of 10
individual photoactivated mitochondria (Figure 3, A and B).
Over the 20-min recording session, the overall fluorescence
intensity for the photoactivated mitochondria in both cell
lines declined by only 7% (Figure 3C). This gradual reduc-
tion is attributed to photobleaching, because examination of
the time-lapse movies reveal that individual mitochondria
undergo gradual reductions in fluorescence intensity
without fluorescence exchange with neighboring mito-
chondria. In contrast, the photoactivated mitochondria in
wild-type cells lose most of their fluorescence within 10
min (Figure 4C).
To examine the issue of mitochondrial outer membrane
fusion, we modified the photoactivation assay by localizing
PA-GFP to the mitochondrial outer membrane through fu-
sion with the targeting sequences of OMP25. We expressed
both mito-DsRed and PA-GFP-OMP25 in cells and used
two-photon excitation to photoactivate a small group of
mitochondria in a region of interest. After photoactivation,
cells were monitored by time-lapse microscopy every 20 s
for 20 min. In wild-type cells, mitochondrial fusion results in
tightly coupled outer and inner membrane fusion (Figure
S4). Such events result in stepwise changes in the fluores-
cence intensity of both fluorescent markers. When a PA-
GFP-OMP25 labeled mitochondrion fuses with a nonacti-
vated mitochondrion, its GFP fluorescence shows a stepwise
decline as its DsRed fluorescence suddenly increases.
In Mfn-null cells, we found that PA-GFP-OMP25 behaved
similarly to mito-PA-GFP, and we never detected evidence
for outer membrane fusion (Figure 4, D and F). From the
time-lapse images of Mfn-null cells, we tracked and quanti-
fied the fluorescence profiles of individual photoactivated
mitochondria as a function of time. These plots indicate that
the fluorescence intensities were stable (Figure 4D). The
averaged fluorescence of the photoactivated mitochondria
declined only 14% after 20 min of continual recording (Fig-
ure 4F). The slightly higher level of photobleaching in this
assay is attributable to the higher laser power necessary to
image PA-GFP-OMP25, which has lower fluorescence than
mito-PA-GFP.
In OPA1-null cells, however, we detected frequent outer
membrane fusion events. The average fluorescence intensity
of the photoactivated mitochondria declined by 42% after 20
min (Figure 4F). When the PA-GFP-OMP25 fluorescence
intensities of individual photoactivated mitochondria were
analyzed, most mitochondria (7 of 10) show stochastic step-
wise drops in intensity that are highly suggestive of outer
mitochondrial fusion (Figures 4E and 5). Although frequent
outer membrane fusion events are observed (see below) in
OPA1-null cells, these events happen less frequently than in
wild-type cells (Figure 4F). Consistent with this idea, OPA1-
null cells have fragmented mitochondrial morphology even
when analyzed with outer membrane markers.
Examination of the time-lapse movies revealed unambig-
uous outer membrane fusion events (Supplemental Movies
1 and 2). Figure 5 shows fluorescence traces of mitochondria
from a time-lapse movie of OPA1-null cells, along with
selected still frames. In the two cases shown, the fluores-
cence traces show a stepwise drop in the PA-GFP fluores-
cence of one mitochondrion that is correlated with a step-
wise increase in the PA-GFP fluorescence of an adjacent
mitochondrion. Examination of the corresponding still
frames (Figure 5) indicates that PA-GFP fluorescence has
been transferred from the first mitochondrion to the adjacent
mitochondrion, which was not photoactivated and therefore
initially contained only mito-DsRed fluorescence. Impor-
tantly, there was no transfer of mito-DsRed fluorescence,
indicating that outer membrane exchange has occurred in
the absence of matrix transfer. The stepwise nature of the
fluorescence change implies that once outer membrane mix-
ing has initiated, it is completed within the 20-s recording
interval.
Ultrastructure of OPA1-Null Cells
These results indicate that whereas mitofusins are essential
for outer membrane fusion and consequently also for inner
membrane fusion, OPA1 functions in only inner membrane
fusion. In OPA1-null cells, frequent mitochondrial outer
membrane events occur but are always uncoupled from
inner membrane fusion (Figure 5). Such uncoupled mem-
brane fusion events would be expected to lead to mitochon-
dria containing multiple matrix compartments in OPA1-null
cells. To test this prediction, we scored mitochondrial pro-
files in OPA1-null cells by thin-section electron microscopy.
Consistent with previous reports using RNAi knockdown
(Olichon et al., 2003; Griparic et al., 2004; Frezza et al., 2006),
we found that OPA1-null cells had severe ultrastructural
defects in the mitochondria, including swollen mitochondria
and defects in cristae organization, such as concentric inner
membranes. Such changes have been attributed to the role of
OPA1 in cristae maintenance (Olichon et al., 2003; Griparic et
al., 2004; Frezza et al., 2006; Meeusen et al., 2006), which
appears to be distinct from its role in membrane fusion. In
addition, however, we found many mitochondria with mul-
tiple matrices. Of 280 mitochondria scored, 83 (30%) had
apparently multiple matrix compartments bounded by a
single outer membrane (Figure 6,A and B). Such mitochon-
drial profiles were not observed in wild-type or Mfn-null
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cells (Figure S5). We calculated three-dimensional electron
tomograms from tilt series of a number of mitochondria to
confirm the nature of the inner membrane defects, and
views of two three-dimensional models derived from seg-
mented tomograms are shown in Figures 6C and 6D. In
both, a single outer membrane encloses two separate matrix
compartments. Mitochondria with multiple matrix compart-
ments could, in principle, arise from inner membrane fission
uncoupled from outer membrane fission or from outer mem-
brane fusion uncoupled from ensuing inner membrane fu-
sion. The fluorescence imaging experiments above indicate
that it is attributable to the latter process.
Similar Defects in Cells Lacking Prohibitins
Prohibitin 1 (Phb1) and Prohibitin 2 (Phb2) are related large
protein complexes residing on the mitochondrial inner mem-
brane that are essential for proper proteolytic processing of
OPA1 (Merkwirth et al., 2008). In the absence of prohibitins,
OPA1 is fully processed into short isoforms only, leading to
severe defects in mitochondrial function. Our results above
would predict that cells lacking prohibtins might also show
defects in inner membrane fusion. To test this prediction, we
used short hairpin RNAi to knockdown the expression of
Phb1. As expected, this knockdown led to reduced levels of
Phb1 (Figure S6). The levels of Phb2 are similarly reduced,
consistent with previous results that the expression of the two
proteins is interdependent (Merkwirth et al., 2008). Knockdown
of Phb1 also led to increased processing of OPA1 predomi-
nantly into the short isoforms (Figure S6). Using time-lapse
imaging, we readily found examples of outer membrane fusion
events uncoupled from inner membrane fusion (Figure 7).
Figure 4. Behavior of matrix and outer membrane markers in Mfn-null and OPA1-null cells. Full fusion and outer membrane fusion were
monitored by measuring the dilution of the matrix marker mito-PA-GFP (A–C) or the outer membrane marker PA-GFP-OMP25 (D–F),
respectively, in Mfn-null (A and D) and OPA1-null (B and E) cells. Panels A, B, D, and E show individual normalized fluorescence traces of
10 individual mitochondria every 20 s throughout the entire 20-min recording session. In a few traces, discontinuities are attributable to brief
defocusing during recording. The data in A and B are averaged to yield the traces in C. The data in D and E are averaged to yield the traces
in F. In E and F, mitochondria from OPA1-null cells demonstrate a much greater decline in PA-GFP-OMP25 fluorescence compared with
Mfn-null cells. Data from 6 mitochondria in wild-type cells were used to obtain the wild-type averages in C; data from 5 mitochondria were
used to obtain the wild-type averages in F. The legend to F is shown in C.
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DISCUSSION
Similarities and Differences Between Yeast and
Mammalian Mitochondrial Fusion
Our results indicate that OPA1 and mitofusins act at distinct
steps during mitochondrial fusion. Most importantly, we
find that, in vivo, deletion of OPA1 in mammalian cells does
not abolish mitochondrial outer membrane fusion. Our
work agrees with previous in vitro work in yeast showing
that Mgm1 is required for inner membrane fusion (Meeusen
et al., 2006). However, it should be noted that yeast lacking
Mgm1 show no outer membrane fusion in vivo (Sesaki et al.,
2003). This difference suggests that fusion of the outer and
inner membranes is not as tightly coupled in mammalian
cells as in yeast cells. The reason for this difference remains
to be determined. However, it is worth noting that the
adaptor protein Ugo1 in yeast physically binds to both Fzo1
and Mgm1 and is thought to coordinate fusion of the outer
and inner membranes (Wong et al., 2003; Sesaki and Jensen,
2004; Hoppins et al., 2009). So far, no mammalian ortholog of
Ugo1 has been found.
We also find that OPA1, unlike mitofusins (Koshiba et al.,
2004), is not required on adjacent mitochondria for fusion to
occurs. This striking distinction implies a difference in mo-
lecular mechanism for these two types of GTPases during
mitochondrial fusion. With in vitro fusion assays with yeast
mitochondria, Mgm1p is required on both mitochondria for
efficient fusion (Meeusen et al., 2006). It is unclear whether
this discrepancy is attributable to the different fusion assays
used or whether it reflects another difference between mam-
malian and yeast mitochondrial fusion.
Implications for Neurodegenerative Disease
Although the neurodegenerative diseases CMT2A and DOA
are both thought to arise from reduced mitochondrial fu-
sion, our results suggest that they impact distinct steps in the
mitochondrial fusion pathway. This insight may help to
understand the pathogenic basis for these diseases. CMT2A,
caused by mutations in Mfn2, is a disease characterized by
degeneration of the longest peripheral nerves (Zuchner et al.,
2004). In contrast, DOA is a disease of retinal ganglion cell
degeneration that leads to atrophy of the optic nerve
(Alexander et al., 2000; Delettre et al., 2000). In both diseases,
a subset of patients show broader and overlapping tissue
involvement, indicating that mitochondrial fusion is impor-
tant to a wider range of cell types (Zuchner and Vance, 2006;
Hudson et al., 2008; Zanna et al., 2008; Zeviani, 2008). The
basis for the tissue-specific differences between these two
diseases is unknown. It will be worth exploring whether
they arise, in part, because of the distinct roles of Mfn2 and
OPA1 in mitochondrial fusion.
Mutations in OPA1 cause autosomal dominant DOA, and
some cases are caused by haploinsufficiency of OPA1 (Delettre
et al., 2002). In addition, mice with a 50% reduction of OPA1
protein have an age-dependent degeneration of retinal gan-
glion cells (Alavi et al., 2007; Davies et al., 2007). In contrast,
our OPA1-null cells lack any OPA1 protein and would be
expected to have a much more severe loss of mitochondrial
fusion compared with cells from patients. Nevertheless, the
preservation of outer membrane fusion even in OPA1-null
cells implies that DOA patients likely have intact outer
membrane fusion.
Every mitochondrial fusion event mediates a dramatic
remodeling between two mitochondria. Fusion of the four
lipid bilayers results in not only mixing of membrane lipids
and proteins but also the merging of mitochondrial matrices.
At a cellular level, loss of mitofusins or OPA1 results in
severe consequences for mitochondrial function, including
heterogeneity in membrane potential, heterogeneity in
mtDNA nucleoids, and greatly reduced respiratory capacity
(Chen et al., 2005; Chen et al., 2007). It is possible that the role
of OPA1 in maintenance of cristae structure (Olichon et al.,
2003; Griparic et al., 2004; Frezza et al., 2006; Meeusen et al.,
2006) may contribute in part to these functional defects,
although it should be noted that yeast Mgm1p is not
necessary for cristae structure when mitochondrial fission
Figure 5. Visualization of outer membrane fu-
sion events in OPA1-null cells. (A) PA-GFP flu-
orescence traces in a pair of mitochondria in an
OPA1-null cell (expressing PA-GFP-OMP25
and mito-DsRed). Mitochondrion b was photo-
activated and initially contained high levels of
PA-GFP fluorescence. Mitochondrion a was not
photoactivated and therefore initially did not
show PA-GFP fluorescence. In frame 2, a step-
wise drop in the PA-GFP fluorescence of b is
matched by an increase the fluorescence of a.
Still frames corresponding to these changes are
shown on the right. The frames before and after
the fluorescence change are shown as a merged
(top), green (middle), or red image (bottom).
The relevant mitochondria involved in each
outer membrane fusion event are labeled. Al-
though exchange of PA-GFP fluorescence oc-
curs, there is no transfer of DsRed. Under our
PA-GFP photoactivation conditions, DsRed is
photobleached. Therefore, photoactivated mito-
chondria are easily visualized by high GFP flu-
orescence and no DsRed fluorescence. (B) An-
other example similar to A. The still frames
shown are from Movies S1 and S2.
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is blocked (Sesaki et al., 2003). Instead, we favor the model
that the defect in mitochondrial inner membrane fusion
underlies the cellular defects in OPA1-null cells. These ob-
servations suggest that inner membrane fusion, perhaps
because of its effect in merging mitochondrial matrices, has
an important physiological function.
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